Monitoring and Tracking in Companies with Small Compliance Departments

Slides:



Advertisements
Similar presentations
4.02 Compliance Training Brian A. Dahl Senior Counsel Takeda Pharmaceuticals North America, Inc. November 14, 2003.
Advertisements

Module N° 4 – ICAO SSP framework
…by your side. …working collaboratively. …to add value.
INTERNATIONAL BEST PRACTICES IN ON-SITE INSPECTIONS OF INSURERS Thomas E Power Senior Manager, Emerging Market Practice Bearing Point.
Approaches to Operating a Compliance Program with a Small Compliance Department The Seventh Annual Pharmaceutical Regulatory and Compliance Congress Best.
RUN YOUR LEGAL DEPARTMENT LIKE A BUSINESS UNIT – HOW TO MAKE A SUCCESSFUL TRANSITION ROB THOMAS, VICE PRESIDENT, MARKET DEVELOPMENT GROUP THOMSON REUTERS.
IT Security Requirements
© 2013 Cengage Learning. All Rights Reserved. 1 Part Four: Implementing Business Ethics in a Global Economy Chapter 8: Developing an Effective Ethics Program.
Building a Compliance Risk Monitoring Program HCCA Compliance Institute New OrleansApril 19, 2005 Lois Dehls Cornell, Esq. Assistant Vice President, Deputy.
PAINTING THE FULL PICTURE
Are you ready for a recall? Medical Device Regulatory, Reimbursement and Compliance Congress March 28, 2007 Willie R. Bryant, Jr. Consultant Stericycle,
Internal Auditing and Outsourcing
1.  The views expressed are those of the speaker and do not necessarily reflect the views of the Federal Reserve Board of Governors, or the Federal Reserve.
Staff Structure Support HCCA Special Interest Group New Regulations: A Strategy for Implementation Sharon Schmid Vice President, Compliance and.
Presenting The Broker-Dealer Certification Tool The Compliance Department Inc. Broker Dealer Compliance Consultants Compliance SCORE Powered by Keane BRMS.
CORPORATE COMPLIANCE Tim Timmons Vice President Compliance and Regulatory Services Health Future, LLC.
Developing and Implementing an Effective Compliance Program Mary Sacilotto,BA,CHC Chief Compliance Officer Alliance, Inc.
Developing an Effective Ethics Program
Managing the Privacy Function at a Large Company Kimberly S. Gray, Esq., CIPP Chief Privacy Officer Highmark Inc.
Establishing A Compliance Program: It Makes Sense
How to Develop Internal Monitoring Programs SEVENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM Stephen F. Mohr Global.
Internal Audit’s Role in Compliance Laurisa Riggan, CPA, CHE Children’s Mercy Hospitals and Clinics September 26, 2000.
Implementing and Auditing Ethics Programs
Module N° 8 – SSP implementation plan. SSP – A structured approach Module 2 Basic safety management concepts Module 2 Basic safety management concepts.
1 Strategies for a Compliant Grant Process CIA Monitoring Obligations A. Monica Jonhart Director-U S Pharmaceuticals Compliance Bristol-Myers Squibb.
Health Care Compliance Association Region VII Compliance Conference August 1, 2003.
Manager ethics Business Ethics Infrastructure Slovak University of Technology Faculty of Material Science and Technology in Trnava.
Pre-Conference III: Auditing, Monitoring and Effective Internal Investigations Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum.
February 20 th, 2007 Board of Directors Meeting Semi-Annual Audit, Compliance, and Enterprise Risk Management Update Steve Byone Chief Financial Officer.
The Audit as a Management Tool Vermont State Auditor’s Office – April 2009.
The Ninth Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum Thomas E. Costa Bristol-Myers Squibb Company This presentation.
IDENTIFYING AND RESPONDING TO POTENTIAL VIOLATIONS David Anderson David Anderson Healthcare Compliance Office, Internal Investigator Genentech, Inc. Dan.
Risk Management & Corporate Governance 1. What is Risk?  Risk arises from uncertainty; but all uncertainties do not carry risk.  Possibility of an unfavorable.
UMBC POLICY ON ESH MANAGEMENT & ENFORCEMENT UMBC Policy #VI
March 14, 2006 Vienna1 The Implementation of the 8th Directive in Hungary Katalin Fekete Vice President Hungarian Chamber of Auditors.
Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum Special Program for Internal/Compliance Audit Professionals: Enterprise Risk.
Agenda for Session Compliance in Clinical Research
August 21 th, 2007 Board of Directors Meeting Semi-Annual Audit, Compliance, and Enterprise Risk Management Update Steve Byone Chief Financial Officer.
Chief Compliance Officer
Company: Cincinnati Insurance Company Position: IT Governance Risk & Compliance Service Manager Location: Fairfield, OH About the Company : The Cincinnati.
DAY 1: OVERVIEW The nature of internal auditing
Chapter 8 Auditing in an E-commerce Environment
Building A Pharmaceutical Compliance Program Presentation to the Sixth Annual Congress on Health Care Compliance February 7, 2003 Janice Toran Fujisawa.
0 Due Diligence Monitoring and Auditing of Third Party Vendors October 28, 2008 Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum.
Internal Controls For Municipalities Vermont State Auditor’s Office – August 2008.
1 Building a Compliance Program in a Small Cap Company The Seventh Annual Pharmaceutical Compliance and Best Practices Forum November 9, 2006 Colleen CravenJanice.
Compliance at the Crossroads: How can the Compliance Profession Move to the Second Generation? A Practical Approach to Integrating Compliance, Risk and.
Current risk and compliance priorities for law firms PETER SCOTT CONSULTING.
National Clinical Assessment Service Medical Director Associate Director (Business Development) Business support and development team Legal services team.
National Clinical Assessment Service Medical Director Associate Director (Business Development) Business support and development team Legal services team.
Insurance Summit 2016 REGULATORY UPDATE. Panel Participants Ray Farmer (Director, South Carolina Department of Insurance) Tim Morris (Hanover Stone Solutions)
Risk Assessment Beginning an Analysis Date by Jim Bowman.
Top things to consider when doing Strategic Planning for Legal
How to Survive an External Quality Assessment
Strategies for Litigation Management and Prevention
Построение культуры integrity в компании Aнар Каримов партнёр «ЭКВИТА»
The Most Important Element to Assure That Your Sales and Marketing Compliance Program is Working Effectively: Monitoring and Auditing Kelly B. Freeman,
Utilizing Internal Audit Metrics to Advance Your Department
The Ten Toughest Challenges for Pharmaceutical and Medical Device Compliance Officers Pharma, Medical Device & Biotech Colloquium June 6, 2005 Participants:
Sarbanes Section 404 Readiness
Structure of the Internal Audit Service
Trading Supervision Obligations
Chapter 8 Developing an Effective Ethics Program
Risk Management: why and how to protect your health center
Safety Self-Inspections
Compliance, Ethics, and Audit
Developing an Effective Compliance Training Program for Pharmaceutical Sales Personnel Kelly B. Freeman, Ph.D. Director, US Affiliate, Compliance and.
Pharmaceutical Congress: Responding to the Guidance
What Healthcare Providers Are Doing to Promote Regulatory Compliance
Governance Issues Learning Objectives
Presentation transcript:

Monitoring and Tracking in Companies with Small Compliance Departments The Seventh Annual Pharmaceutical Regulatory and Compliance Congress Best Practices Forum Retta M. Riordan, Moderator Business Ethics & Compliance Officer Organon USA Inc., Roseland, NJ Thomas Glavin Vice President and Deputy Compliance Officer Shire Pharmaceuticals Inc., Wayne, PA Scot Steinheiser Senior Manager, Corporate Compliance Astellas US LLC, Deerfield, IL Riordan et al--Trk3.01@2pm PC

Advantages & Disadvantages of Monitoring with Small Compliance Departments Monitoring is one of the 7 Elements of a corporate compliance program Various challenges facing Small Compliance Depts. Resources—Human and financial State of IS/Finance systems for tracking Decentralization of Data Priority overload No small department exception in the 7 Elements

Advantages & Disadvantages of Monitoring with Small Compliance Departments (cont’d) But there are distinct advantages, too Nimble Flexible Know everyone, and everyone knows you Can track manually, if necessary Less bureaucratic Less siloed—people are used to wearing many hats and working as teams

Magic Bullets? Setting Monitoring Priorities Human Resources Challenge Financial Resources Challenge Handling the Data What to do with Monitoring Results Fixing the Problem Viewing the Results as an Opportunity Training, Training, Training

Setting Priorities for Monitoring at a Small Company How do you determine what to monitor? Conduct a risk assessment Mine the CIAs Review OIG Guidance Listen to statements of government officials Review OIG Work Plans and Semi-Annual Reports How do you prioritize the programs/practices you have identified? Rolling cycle Greasy wheel Gut feel Follow the money Constantly reassess and reprioritize, as necessary

Resource Challenges—Human Problems: Not enough people in small compliance dept. to monitor targeted programs/practices You cannot be everywhere Possible Solutions: Use personnel not in the compliance function Legal, Regulatory, Medical, Audit, Sales/Marketing Operations Lead without authority Buy external help Consulting company Law firm

Resource Challenges—Financial Problems: Not enough heads to do it Not enough $ to pay to have it done Possible Solutions: Combine/Share budgets Legal Finance/Audit Make the business case for involvement of other functions/departments Program Efficiencies Accountability and Control

Decentralization of Disparate Data in Sm(all) Companies Systems and Silos Expense Reporting Promotional Spend Speaker Program Attendance Department tracking inconsistent Sales Representatives + Warehouse + Vendors = Headaches all around

Decentralization of Disparate Data in Sm(all) Companies (cont’d) Magic button or digits to aggregate data Staffing limitations Annual Certifications

After the Storm (Post-Monitoring Phase) What is uncovered must be addressed Avoid Analysis Paralysis Active Coaching Positive Remedial Action Plan Additional Training

After the Storm (Post-Monitoring Phase) (cont’d) Update Policies and Procedures as needed Adjust systems or processes to fill the gap Further investigation may be warranted Coordinate disciplinary action with Department Management and Human Resources

Disclaimer The views expressed and ideas presented in this session are those of the speakers and are not necessarily shared by the presenters’ employers. Any examples provided are hypotheticals and should not be attributed to any individual company.